nafoxidine has been researched along with Hyperplasia in 1 studies
Nafoxidine: An estrogen antagonist that has been used in the treatment of breast cancer.
Hyperplasia: An increase in the number of cells in a tissue or organ without tumor formation. It differs from HYPERTROPHY, which is an increase in bulk without an increase in the number of cells.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Nafoxidine (NAF) acts as an estrogen agonist or antagonist depending on the animal model used." | 1.27 | Response of the mouse uterus to nafoxidine stimulation: agonism and antagonism. ( Fox-Davies, C; Korach, KS; Newbold, RR; Quarmby, VE, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Quarmby, VE | 1 |
| Fox-Davies, C | 1 |
| Newbold, RR | 1 |
| Korach, KS | 1 |
1 other study available for nafoxidine and Hyperplasia
| Article | Year |
|---|---|
Response of the mouse uterus to nafoxidine stimulation: agonism and antagonism.
Topics: Animals; Estradiol; Female; Hyperplasia; Mice; Mice, Inbred ICR; Nafoxidine; Organ Size; Pyrrolidine | 1988 |